Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
influenza
|
| gptkbp:annualReport |
yes
|
| gptkbp:approvedBy |
1980s
adults children |
| gptkbp:ATCCode |
J07BB02
|
| gptkbp:contains |
egg protein
inactivated influenza virus hemagglutinin antigen thimerosal-free (most presentations) |
| gptkbp:contraindication |
hypersensitivity to vaccine components
severe allergy to egg protein |
| gptkbp:countryOfOperation |
gptkb:France
many countries worldwide |
| gptkbp:form |
suspension for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vaxigrip
|
| gptkbp:indication |
prevention of influenza
|
| gptkbp:manufacturer |
gptkb:Sanofi_Pasteur
|
| gptkbp:pregnancyCategory |
can be used in pregnancy
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
intramuscular
subcutaneous |
| gptkbp:sideEffect |
fever
headache muscle aches injection site pain |
| gptkbp:storage |
2-8°C
|
| gptkbp:WHOModelListOfEssentialMedicines |
yes
|
| gptkbp:WHOPrequalified |
yes
|
| gptkbp:bfsParent |
gptkb:Sanofi_Aventis
gptkb:赛诺菲 |
| gptkbp:bfsLayer |
6
|